← Research library

Inhibitory effect of 2-substituted benzimidazoles on lymphocyte mitogenesis is associated with AhR-dependent mechanisms

Lab research · 2009

What was studied
Healthy-donor T cells stimulated with anti-CD3; benzimidazoles and TCDD interaction experiment
Main finding
At the reported Bemitil concentration, the table gives only 3±3% inhibition of mitogenesis. The combination with TCDD differed from the Bliss-model expectation. This supports an experimental interaction question, not a claim that Bemitil strongly suppresses human immunity.

Study data at a glance

Participants or experimental model
Healthy-donor T cells stimulated with anti-CD3; benzimidazoles and TCDD interaction experiment
Reported results
At the reported Bemitil concentration, the table gives only 3±3% inhibition of mitogenesis. The combination with TCDD differed from the Bliss-model expectation. This supports an experimental interaction question, not a claim that Bemitil strongly suppresses human immunity.
Study limitations and source details

Study limitations

  • Conference abstract and indexed table excerpt, not a full clinical study.
  • AhR involvement is a proposed mechanism; direct receptor binding and clinical immunosuppression were not demonstrated.
  • No MS patients, demyelination outcome or clinical benefit assessment.

Source details

Russian conference abstract; indexed PDF excerpt

The summary reflects the results reported in the cited source.

Indexed abstract and table text reviewed

Sources checked

Citation

In vitroRussian-language source

E. S. Sibiryak, S. V. Sadovnikov, S. V. Sibiryak. Inhibitory effect of 2-substituted benzimidazoles on lymphocyte mitogenesis is associated with AhR-dependent mechanisms Medical Immunology. 2009;11(4–5):335. Conference abstract

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards